CN Bio Innovations Limited announces that it has licensed from Vanderbilt University three patents and applications, and software, covering microfluidics technologies relevant to the company’s Organs-on-Chips products and IP portfolio.
The agreement includes exclusive rights to applications claiming priority from US 15/191,092, as well as non-exclusive rights to US 9,618,129 and applications claiming priority from US 13/877,925.
Developed by Professor John Wikswo, Gordon A. Cain University Professor, A. B. Learned Professor of Living State Physics and Founding Director of the Vanderbilt Institute for Integrative Biosystems Research and Education (VIIBRE), the licensed technologies were devised for Organ-on-a-Chip applications where the micropumps and valves allowed interactions between two or more organ mimics under automatic computer control. The technologies also allow scientists to simulate vital organs that are missing from multi-organ devices, for instance hormone-secreting organs, improving the accuracy with which such devices can mimic human physiology.
Continue reading the article here.